Inhibitory effect of oxymatrine on serum hepatitis B virus DNA in HBV transgenic mice

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 8

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

443

HTML

2471

Tables (1-1)

201

Sum=3115

Apr 15, 2004 (publication date) through Dec 22, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Viral Hepatitis

World J Gastroenterol. Apr 15, 2004; 10(8): 1176-1179
Published online Apr 15, 2004. doi: 10.3748/wjg.v10.i8.1176

Table 1 Results of HBV DNA quantitation in transgenic mice before and after oxymatrine treatment (fg/mL) (n, mean ± SD)

^bP < 0.01 vs before treatment,

^dP < 0.01 (vs after treatment in groups A and B).

Citation: Lu LG, Zeng MD, Mao YM, Fang JY, Song YL, Shen ZH, Cao AP. Inhibitory effect of oxymatrine on serum hepatitis B virus DNA in HBV transgenic mice. World J Gastroenterol 2004; 10(8): 1176-1179
URL: https://www.wjgnet.com/1007-9327/full/v10/i8/1176.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i8.1176